Welcome to the Hope Bio Blog

How and why to enroll in FDA-authorized, DoD-backed research using Hope Bio's cells in TBI | Written by Jan Shultis Last year, Hope Biosciences was privileged to announce a four-year, nearly $5 million clinical trial grant awarded by the Department of Defense’s Office of Congressionally Directed Medical Research Programs (CDMRP) to evaluate if intravenously infused Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) reduce chronic neuroinflammator

Written by Jan Shultis In 2023, Texas-based biopharmaceutical company Hope Biosciences, LLC cultured approximately 170 billion adult stem cells for use in dozens of disease and injury conditions, including in 18 FDA-authorized research protocols. It was a year that saw a new volume of peer-reviewed publications, conference presentations, and community engagements. Also in 2023, Hope Biosciences increasingly became a household name in skincare, with a partner’s very public lau

Thoughts in Honor of Atomic Veterans Day | Written by Jan Shultis Atomic Veterans Day, first designated by President Ronald Reagan in 1983, recognizes and honors the select group of military veterans who served in or around nuclear operations and nuclear campaigns. “Atomic veterans” are American service members who participated in nuclear tests between 1945 and 1962, served with United States military forces in or around Hiroshima and Nagasaki through mid-1946, or were held a